Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
346.00
+1.50 (0.44%)
Dec 12, 2025, 4:00 PM EST - Market closed
Cencora Market Cap
Cencora has a market cap or net worth of $67.12 billion as of December 12, 2025. Its market cap has increased by 39.78% in one year.
Market Cap
67.12B
Enterprise Value
72.10B
1-Year Change
39.78%
Ranking
Category
Stock Price
$346.00
Market Cap Chart
Since December 1, 1998, Cencora's market cap has increased from $1.54B to $67.12B, an increase of 4,266.21%. That is a compound annual growth rate of 14.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 67.12B | 54.56% |
| Dec 31, 2024 | 43.43B | 5.35% |
| Dec 29, 2023 | 41.22B | 20.95% |
| Dec 30, 2022 | 34.08B | 23.22% |
| Dec 31, 2021 | 27.66B | 38.52% |
| Dec 31, 2020 | 19.97B | 14.05% |
| Dec 31, 2019 | 17.51B | 11.03% |
| Dec 31, 2018 | 15.77B | -21.26% |
| Dec 29, 2017 | 20.02B | 16.36% |
| Dec 30, 2016 | 17.21B | -19.30% |
| Dec 31, 2015 | 21.33B | 8.16% |
| Dec 31, 2014 | 19.72B | 21.91% |
| Dec 31, 2013 | 16.17B | 59.07% |
| Dec 31, 2012 | 10.17B | 5.83% |
| Dec 30, 2011 | 9.61B | 1.90% |
| Dec 31, 2010 | 9.43B | 25.55% |
| Dec 31, 2009 | 7.51B | 34.82% |
| Dec 31, 2008 | 5.57B | -26.08% |
| Dec 31, 2007 | 7.54B | -12.74% |
| Dec 29, 2006 | 8.64B | 0.04% |
| Dec 30, 2005 | 8.63B | 39.95% |
| Dec 31, 2004 | 6.17B | -2.03% |
| Dec 31, 2003 | 6.30B | 8.40% |
| Dec 31, 2002 | 5.81B | -11.90% |
| Dec 31, 2001 | 6.59B | 149.72% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 913.03B |
| Johnson & Johnson | 507.20B |
| AbbVie | 392.82B |
| UnitedHealth Group | 308.91B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 247.11B |
| Novo Nordisk | 223.42B |